Education:

• October 2008- July 2014 Medical School, University of Crete, Greece
• November 2011- September 2013 Basic science- translational research tools: rtPCR, DNA/RNA extraction, Immunofluorescence, Laboratory of Tumor’s Biology, Medical School, University of Crete
• October 2018- ongoing: PhD Candidate- prospective translation research trial about adjuvant treatment and circulating biomarkers in colorectal cancer.

Academic Experience:

• September 2014- ongoing: Member of research team, Laboratory of Translational Oncology, University of Crete, Medical School, Greece
• February 2022- October 2023: co-Investigator, Clinical Trials department, Department of Medical Oncology, University Hospital of Heraklion. Plenty of clinical trials, mainly intervantional: breast, lung, pancreas, colorectal, basket trials etc- phase I/II/III, registry studies
• February 2020- ongoing: lecture ‘Liquid biopsy in colorectal cancer’, Postgraduate programme: ‘Surgery of colon, rectum and anus’, Academic years: 2021-2024, Medical School, University of Thessaly, Greece
• January 2024: lecture ‘Breast Cancer’, Undergraduate programme, 6th year, Academic year: 2023-2024, Medical School, European University of Cyprus, Nicosia, Cyprus
• Scholarships for academic work/research:
  • February 2019, November 2022 Phd research- Hellenic Society of Medical Oncology
  • November 2002, November 2023 Scholarships of excellence-Legacy of Maria Manasaki, University of Crete
  • November 2022 Reward of excellence in clinical trials Lilly Pharmaserve

• July 2015- September 2019: Resident of Medical Oncology- Second Internal Medicine Department, Department of Hematology, Department of Oncology, Venizeleion General Hospital of Heraklion, Crete
• July 2015- September 2018: Second Department of Internal Medicine
• December 2016- December 2017: Infectious disease/ HIV physician associate
• September 2018-April 2019: Department of Hematology
• April 2019- September 2019: Department of Oncology
• September 2019- October 2023: Medical Oncology Department, University Hospital of Herakleion, Crete, Greece, Residency program

• February 2020- April 2023: Greek Academy of Oncology
• September 2021: Distance learning course: ‘Oncogenomics for health professionals’ , Instituto Superiore di Sanita and Universita Cattolica del Sacro Cuore, Rome, Italy
• February 2022: Good Clinical Practice certification- WHO
• October 2023: Certification of specialty in Medical Oncology-solid tumors, Ministry of Health, Greece (by exam)
• October 2023: Certification of Excellent knowledge in the field of Medical Oncology- European Society of Medical Oncοlogy (by exam)

More than 15 publications in international peer-reviewed journals (check all at Asimina Koulouridi @scholar.google https://scholar.google.com/citations?user=290byGkAAAAJ&hl=el&oi=ao). Some of them:

• ‘Evaluation of the detection of Toll-like Receptors(TLRs) n cancer development and progression in patients with colorectal cancer’ I.Messaritakis, M.Stogianitsi, A.Koulouridi, M.Sfakianaki, A.Voutsina, A.Sotiriou, E.Athanasakis, E.Xynos, D.Mavroudis, M.Tzardi, J.Souglakos,  PLoS One
• ‘Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer’ I.Messaritakis, M.Sfakianaki, C.Papadaki, A.Koulouridi, N.Vardakis, F.Koinis, D.Hatzidaki, N.Georgoulia, A.Kladi, A.Kotsakis, J.Souglakos, V.Georgoulias, Cancer Chemother Pharmacol
• ‘Vitamin D receptor gene polymorphisms and colorectal cancer risk in the Greek population’ I.Messaritakis, A.Koulouridi, M.Sfakianaki, Κ.Vogiatzoglou, N.Gouvas, E.Athanasakis, J.Tsiaousis, E.Xynos, D.Mavroudis, M.Tzardi,  Souglakos J, Cancers
• ‘Immunotherapy in solid tumors and gut microbiota: The correlation- a special reference to colorectal cancer’ A.Koulouridi, I.Messaritakis, M.Gouvas, J.Tsiaoussis, J.Souglakos, Cancers
• ‘Detection of circulating tumor cells and DNA fragments in stage III colorectal cancer patients under three versus six months of adjuvant treatment’ A.Koulouridi, I.Messaritakis, E.Theodorakis, M.Chondrozoumaki, M.Sfakianaki, N.Gouvas, J.Tsiaoussis, D.Mavroudis, M.Tzardi, J.Souglakos, Cancers
• ‘Prognostic Value of KRAS Mutations in Colorectal Cancer Patients’. Koulouridi A, Karagianni M, Messaritakis I, Sfakianaki M, Voutsina A, Trypaki M, Bachlitzanaki M, Koustas E, Karamouzis MV, Ntavatzikos A, Koumarianou A, Androulakis N, Mavroudis D, Tzardi M, Souglakos J. Cancers
• ‘Investigation of Microbial Translocation, TLR and VDR Gene Polymorphisms, and Recurrence Risk in Stage III Colorectal Cancer Patients’. Messaritakis I, Koulouridi A, Boukla E, Sfakianaki M, Vogiatzoglou K, Karagianni M, Gouvas N, Tsiaoussis J, Xynos E, Athanasakis E, Mavroudis D, Tzardi M, Souglakos J. Cancers

• Member of digestive cancers study group (EMKAPES)
• Member of young Greek Oncologists group (ONEO)
• Member of European Society of Oncology (ESMO)
• Member of American Society of Clinical Oncology (ASCO)